Article
J. Agric. Food Chem., Vol. 57, No. 14, 2009 6091
pressure. The resulting extract was (70 g) chromatographed over silica gel
(60-120 mesh) and eluted with n-hexane/ethyl acetate combinations
of increasing polarity. Plumbagin (12 g) was obtained by elution with
n-hexane/ethyl acetate, 99:1.
130.39, 131.80, 135.60 147.12, 159.62, 169.94, 171.60, 180.80, 183.31.
ESIMS m/z (rel.int.): 374 [Mþ] (C19H22N2O6) (23), 331 [Mþ-COCH3] (4),
304 (11), 260 (63), 248 (47), 234 (79), 220 (9), 203 (100), 175 (33), 147 (11),
99.1 (15).
General Procedure for the Synthesis of Compound 2. To a solution
of plumbagin (1) (0.2 g, 1.0638 mmol) in dichloromethane (10 mL) at room
temperature was added CH3I (1.39 mmol) and freshly prepared Ag2O
(0.05 mmol). The resultant mixture was stirred for 10 h at room
temperature. After completion of the reaction (monitored by TLC), the
reaction mixture was filtered, and then the filtrate was concentrated to
dryness. The residue thus obtained was purified by column chromatogra-
phy with the elution of n-hexane/ethyl acetate, 90:10, to afford 5-O-methyl
plumbagin (2) as yellow needles (11).
2-(8-Methoxy-3-methyl-1,4-dioxo-1,4-dihydronaphthalene-
2-ylamino) ethyl 2-acetamido-3-mercaptopropanoate (4c).
The title compound was prepared by the reaction of compound 3 (0.050 g,
0.13 mmol) with N-acetyl cysteine (0.0426 g, 0.207 mmol). Yield: 42%. mp:
25
119 °C; [R]D þ 6.5° (c1, H2O). IR (KBr) νmax: 3329 (NH), 2923, 1740 (ester
CdO), 1660 (R,β unsaturated CdO), 1575, 1449, 1273, 747 cm-1. 1H NMR
(300 MHz, CDCl3): δ 2.03 (s, 3H, 90-CH3), 2.24 (s, 3H, 2-CH3), 2.32 (d, 2H,
J=7.5 Hz, H-100), 3.84 (dd, 2H, J=6.8 Hz, 14.8 Hz, H-20), 3.98 (s, 3H,
5-OMe), 4.32(dd, 2H, J=6.8 Hz, 14.8 Hz, H-30), 4.73 (t, 1H, J=7.3 Hz, H-60),
7.15 (dd, 1H, J=1.1, 8.5 Hz, H-6), 7.62 (t, 1H, J=7.5 Hz, 8.5 Hz, H-7), 7.75
(dd, 1H, J=1.1 Hz, 7.5 Hz, H-8). 13C NMR (75 MHz, CDCl3,): δ 11.03,
14.12, 22.83, 27.30, 31.37, 51.75, 56.34, 64.35, 115.82, 118.06, 119.16, 131.22,
135.58, 147.24, 159.61, 170.97, 173.04, 180.83, 183.34. ESIMS m/z (rel.int.):
407 [MþþH] (C19H22N2SO6) (23), 373 [Mþ-SH] (8), 315 [373-58] (29), 301
(43), 288 (12), 260 (13), 185 (100), 155 (10), 93 (15).
Procedure for the Synthesis of Compound 3. To a solution of 5-O-
methyl plumbagin (2) (1 mmol) in dry dichloromethane (10 mL) under
nitrogen atmosphere was added dropwise 2-amino ethanol (1.5 mmol) at
room temperature. The resulting orange colored solution was stirred for
1 h at room temperature. The reaction was monitored by TLC, and after
completion, the reaction mixture was concentrated to dryness. The resi-
due was purified by column chromatography using dichloromethane/
methanol (99:1) to yield the Michael adduct (3) as red needles. Yield: 68%.
mp: 126 °C. IR (KBr) νmax: 3312 (NH), 1662 (R,β unsaturated CdO),
1555, 1275, 1038 cm-1. 1H NMR (CDCl3, 300 MHz): δ 2.24 (3H, s, H-2,
-CH3), 3.74 (2H, dd, J=6.8 Hz, 14.8 Hz, H-20), 3.85 (2H, dd, J=6.8 Hz,
14.8 Hz, H-30), 3.98 (3H, s, -OMe), 7.15 (1H, dd, J=1.1 Hz, 8.5 Hz, H-6),
7.62 (1H, t, J=7.5 Hz, 8.5 Hz, H-7), 7.75 (1H, dd, J=1.1 Hz, 7.5 Hz, H-8);
13C NMR (75 M Hz, CDCl3): δ 14.43, 50.95, 56.34, 64.35, 115.55, 118.06,
119.36, 128.65, 135.58, 135.64, 147.24, 161.02, 180.83, 183.34. ESIMS m/z
(rel.int.): 284 [Mþ23] (22), 261 [MþH] (C14H15NO4) (15), 201(100), 175 (7),
147 (34).
2-(8-Methoxy-3-methyl-1,4-dioxo-1,4-dihydronaphthalene-
2-ylamino) ethyl 2-acetamido-4-(methyl thio)butanoate
(4d). The title compound was prepared by the reaction of compound 3
(0.050 g, 0.13 mmol) with N-acetyl methionine (0.039 g, 0.204 mmol).
25
Yield: 68%. mp: 122 °C; [R]D þ25.9° (c 1, H2O). IR (KBr) νmax: 3329
(NH), 2923, 1740 (ester CdO), 1660 (R,β unsaturated CdO), 1575, 1449,
1273, 747 cm-1 1H NMR (300 MHz, CDCl3): δ 1.49 (s, 3H, 400-CH3),
.
1.95-1.97 (2H, m, H-100), 2.03 (s, 3H, 90-CH3), 2.24 (s, 3H, 2-CH3), 2.49
(t, 2H, J=7.2 Hz, H-200), 3.84 (dd, 2H, J=6.8, 14.8 Hz, H-20), 3.98 (s, 3H,
5-OMe), 4.44 (dd, 2H, J=6.8 Hz, 14.8 Hz, H-30), 4.63 (t, 1H, J=7.3 Hz,
H-60), 7.15 (dd, 1H, J=1.1 Hz, 8.5 Hz, H-6), 7.62 (t, 1H, J=7.5 Hz, 8.5 Hz,
H-7), 7.75 (dd, 1H, J=1.1 Hz, 7.5 Hz, H-8). 13C NMR (75 MHz, CDCl3):
δ 11.04, 14.12, 15.49, 22.68, 29.35, 31.37, 44.10, 51.73, 56.36, 64.52, 112.29,
115.93, 119.16, 130.95, 135.60, 147.13, 159.64, 170.12, 171.98, 180.86,
183.35. ESIMS m/z (rel.int.): 435 [MþþH] (C21H26N2SO6) (17), 419 [Mþ-
CH3] (20), 408 [Mþ-CO] (45), 301 (17), 288 (62), 260 (13), 185 (41), 155
(100), 93 (15).
General Procedure for the Synthesis of Derivatives 4a-4k. To a
cooled solution (0 °C) of 3 (1 equiv) in dry dichloromethane (10 mL) under
nitrogen atmosphere was added N,N0-dicyclohexylcarbodimide and (1.5
equiv) and a catalytic amount of 3-hydroxy benzotriazole. N-Acetyl-L-
amino acid (1.2 mmol) was added after stirring for 15 min, and stirring was
continued at room temperature. After completion of the reaction (mon-
itored by TLC), the reaction mixture was filtered to remove the precipi-
tated dicyclohexylurea. The filtrate was evaporated under reduced
pressure, and the residue was purified by silica gel (100-200 mesh) column
chromatography using dichloromethane/methanol (98:2) as eluent to
afford the corresponding plumbagin derivatives (4a-4k). The structures
of the new derivatives were confirmed by the spectral analyses such as
FTIR, 1H NMR, 13C NMR, and mass spectroscopy.
2-(8-Methoxy-3-methyl-1,4-dioxo-1,4-dihydronaphthalene-
2-ylamino) ethyl 2-acetamido-3-methyl Pentanoate (4e). The
title compound was prepared by the reaction of compound 3 (0.050 g, 0.13
mmol) with N-acetyl isoleucine (0.036 g, 0.208 mmol). Yield: 30%. mp: 98
°C; [R]D þ40.0 (c1, H2O). 1H NMR (300 MHz, CDCl3): δ 0.89 (d, 3H, J=
25
5.8 Hz, 100-CH3), 0.90 (t, 3H, J=7.2 Hz, 300-CH3), 1.25-1.28 (2H, m, H-
200), 1.48-1.52 (1H, m, H-100), 2.03 (s, 3H, 90-CH3), 2.24 (3H, s, 2-CH3),
3.84 (dd, 2H, J=6.8 Hz, 14.8 Hz, H-20), 3.98 (s, 3H, -OMe), 4.44 (dd, 2H,
J=6.8 Hz,14.8 Hz, H-30), 4.63 (dd, 1H, J=7.2 Hz, H-60), 7.15 (dd, 1H, J=
1.1, 8.5 Hz, H-6), 7.62 (t, 1H, J=7.5 Hz, 8.5 Hz, H-7), 7.75 (dd, 1H, J=1.1
Hz, 7.5 Hz, H-8). 13C NMR (75 MHz, CDCl3,): δ 11.03, 14.10, 15.42,
22.83, 23.05, 29.35, 30.00, 38.65, 51.73, 56.34, 64.35, 115.90, 118.06,
119.16, 128.59, 135.58, 147.24, 159.61, 170.97, 173.04, 180.83, 183.34.
ESIMS m/z (rel.int.): 417 [MþþH] (C22H28N2O6), 395 (16), 301 (12), 261
(38), 217 (100), 195 (15), 173 (27), 101 (39), 93 (18), 78 (21), 65 (34).
2-(8-Methoxy-3-methyl-1,4-dioxo-1,4-dihydronaphthalene-
2-ylamino) ethyl 2-acetamido-4-methyl Pentanoate (4f). The
title compound was prepared by the reaction of compound 3 (0.050 g, 0.13
mmol) with N-acetyl leucine (0.036 g, 0.208 mmol). Yield: 80%. mp: 96 °C;
2-(8-Methoxy-3-methyl-1,4-dioxo-1,4-dihydronaphthalene-
2-ylamino)ethyl-2-acetamidoacetate (4a). The title compound
was prepared by the reaction of compound 3 (0.050 g, 0.13 mmol) with
N-acetyl-glycine (0.0243 g, 0.207 mmol). Yield: 78%. mp: 105 °C. IR (KBr)
ν
max: 3312 (NH), 1747 (ester CdO), 1662 (R,β unsaturated CdO), 1555,
1275, 1038, 745 cm-1. 1H NMR (300 MHz, CDCl3): δ 2.03 (s, 3H, 90-CH3),
2.24 (s, 3H, 2-CH3), 3.14 (dd, 2H, J=6.8 Hz, 14.8 Hz, H-20), 3.98 (s, 3H,
5-OMe), 3.90 (dd, 1H, J=5.4 Hz, 17.1 Hz, H-60a), 4.03 (dd, 1H, J=5.4 Hz,
17.1 Hz, H-60b), 4.27 (dd, 2H, J=6.8 Hz, 14.8 Hz, H-30), 7.15 (dd, 1H,
J=1.1 Hz, 8.5 Hz, H-6), 7.62 (t, 1H, J=7.5 Hz, 8.5 Hz, H-7), 7.75 (dd, 1H,
J=1.1 Hz, 7.5 Hz, H-8). 13C NMR (75 MHz, CDCl3,): δ 11.04, 14.03, 22.83,
50.95, 56.34, 64.35, 115.93, 118.06, 119.16, 128.80, 135.58, 135.69, 147.24,
159.61, 170.97, 173.04, 180.83, 183.34. ESIMS m/z (rel.int.): 383 [Mþ23],
361 [MþH] (C18H20N2O6) (15), 318 [Mþ-COCH3] (13), 300 [318-H2O] (37),
273 (25), 260 (15), 244 (8) 225 (25), 212 (17), 149 (100), 121 (83), 99 (30).
2-(8-Methoxy-3-methyl-1,4-dioxo-1,4-dihydronaphthalene-
2-ylamino)ethyl2-acetamidopropanoate (4b). The title com-
pound was prepared by the reaction of compound 3 (0.050 g, 0.13 mmol)
with N-acetyl alanine (0.027 g, 0.207 mmol). Yield: 62%. mp: 109 °C;
25
[R]D þ14.5 (c1, H2O). IR (KBr) νmax: 3339 (NH), 2925, 1737(ester CdO),
1657 (R,β unsaturated CdO), 1576, 1452, 1275 cm-1. 1H NMR (300 MHz,
CDCl3,): δ 0.90 (d, 6H, J=9.3 Hz, 300-CH3, 400-CH3), 1.61-1.63 (1H, m, H-
100), 1.78-1.82 (1H, m, H-200), 2.03 (s, 3H, H-90), 2.24 (s, 3H, 2-CH3), 3.84
(dd, 2H, J=6.8 Hz, 14.8 Hz, H-20), 3.98 (s, 3H, -OMe), 4.44 (dd, 2H, dd, J=
6.8 Hz, 14.8 Hz, H-30), 4.63 (t, 1H, J=7.3 Hz, H-60), 7.15 (dd, 1H, J=1.1,
8.5 Hz, H-6), 7.62 (dd, 1H, J=7.5 Hz, 8.5 Hz, H-7), 7.75 (dd, 1H, J=1.1
Hz, 7.5 Hz, H-8). 13C NMR (75 MHz, CDCl3): δ 11.03, 14.10, 22.83, 22.99,
24.88, 31. 24, 42. 07, 41.06, 51.15, 56.34, 64.35, 115. 90, 118.06, 119.16,
128.59, 135.58, 147.24, 159.61, 170.97, 173.04, 180.83, 183.34. ESIMS m/z
(rel.int.): 417 [MþþH] (C22H28N2O6) (18), 395 (16), 301 (12), 261 (38), 217
(100), 195 (15), 173 (27), 101 (39), 93 (18), 78 (21), 65 (34).
20
[R]D þ14.5° (c 1, H2O). IR (KBr) νmax: 3314 (NH), 1742 (ester CdO
stretch), 1665 (R,β unsaturated CdO), 1552, 1270,1034, 742 cm-1 1H
.
NMR (300 MHz, CDCl3): δ 1.46 (d, 3H, J=6.8 Hz, 60-CH3), 2.03 (s, 3H,
H-90), 2.24 (s, 3H, 2-CH3), 3.87 (dd, 2H, J=6.8 Hz, 14.8 Hz, H-20), 3.98 (s,
3H, 5-OMe), 4.35 (dd, 2H, J=6.8 Hz, 14.8 Hz, H-30), 4.45-4.46 (1H, m, H-
60), 7.15 (dd, 1H, J=1.1, 8.5 Hz, H-6), 7.62 (t, 1H, J=7.5 Hz, 8.5 Hz, H-7),
7.75 (dd, 1H, J=1.1 Hz, 7.5 Hz, H-8). 13C NMR (75 MHz, CDCl3,): δ
11.02, 14.10, 22.83, 50.95, 53.34, 56.34, 64.31, 115.93, 118.08, 119.13,
2-(8-Methoxy-3-methyl-1,4-dioxo-1,4-dihydronaphthalene-
2-ylamino) ethyl 2-acetamido-3-phenyl Propanoate (4g). The
title compound was prepared by the reaction of compound 3 (0.050 g,